Bill Information > SB 5594
Search for another bill or initiative:
Search
SB 5594 - 2025-26
Revised for Engrossed: Concerning biosimilar medicines and interchangeable biological products.
Original: Concerning biosimilar medicines.
Original: Concerning biosimilar medicines.
Bill History
2025 REGULAR SESSION
IN THE SENATE
Jan 30
First reading, referred to Health & Long-Term Care.
(View Original Bill)
Feb 11
Public hearing in the Senate Committee on Health & Long-Term Care at 10:30 AM.
(Committee Materials)
Feb 18
Executive action taken in the Senate Committee on Health & Long-Term Care at 10:30 AM.
(Committee Materials)
HLTC - Majority; 1st substitute bill be substituted, do pass.
(View 1st Substitute)
(Majority Report)
Feb 19
Passed to Rules Committee for second reading.
Mar 5
Placed on second reading by Rules Committee.
Mar 11
1st substitute bill substituted (HLTC 25).
(View 1st Substitute)
Floor amendment(s) adopted.
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
(View 1st Engrossed)
(View Roll Calls)
IN THE HOUSE
Mar 13
First reading, referred to Health Care & Wellness.
Mar 26
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
(Committee Materials)
Apr 1
Scheduled for executive session in the House Committee on Health Care & Wellness at 1:30 PM (Subject to change).
(Committee Materials)
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos